Some European Countries Unprepared to Move Future Alzheimer's Treatment into Rapid Clinical Use
The health care systems in some European countries lack the capacity to rapidly move a disease-modifying treatment for Alzheimer's disease from approval into widespread clinical use, which could leave 1 million people without access to transformative care if such a breakthrough occurs.